![]() |
|
|
Vol. 283, Issue 2, 557-565, 1997
Department of Pharmacology, Uniformed Services University of the
Health Sciences, Bethesda, Maryland
Morphine treatment of rats (60-70 mg/kg/day, 7 days) reduced
opioid receptor-mediated inhibition of adenylyl cyclase activity in
caudate putamen without any change in regulation by µ receptors. Earlier studies suggested that dopamine D1 and µ opioid
receptors that regulate adenylyl cyclase are expressed preferentially
by striato-nigral neurons, whereas adenosine A2a and
1 opioid receptors are expressed preferentially by
striato-pallidal neurons. Chronic morphine treatment also resulted in a
reduction of dopamine D2 receptor-mediated inhibition of
A2a receptor-stimulated adenylyl cyclase. Treatment with a
D2 receptor antagonist (eticlopride; 1 mg/kg/day) for 7 days reduced D1 receptor stimulation of adenylyl cyclase.
In contrast, chronic treatment with a D1 receptor
antagonist R(+)-7-chloro-8-dihydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine HCL (SCH 23390; 2.5 mg/kg/day) resulted in a reduction of
1 and
2 opioid inhibition of adenylyl
cyclase, with no change in the inhibitory activity of a µ agonist.
The inhibitory activity of the D2 agonist quinelorane
against adenosine A2a-activated enzyme was also reduced by
this treatment. Thus chronic D1 blockade, like chronic
morphine treatment, appears to cause a selective impairment of the
regulation of adenylyl cyclase in A2a receptor-expressing striato-pallidal neurons. D2 receptor activation appears to
play an important role in the desensitization of
receptors, because concurrent administration of the D2 antagonist eticlopride
with morphine prevented the densitization of
and D2
receptors. Similar results were obtained in nucleus accumbens, which
suggests a role for D2 receptor desensitization in the
adaptive response of this brain region to chronic morphine.
This article has been cited by other articles:
![]() |
M. Elovainio, M. Jokela, M. Kivimaki, L. Pulkki-Raback, T. Lehtimaki, N. Airla, and L. Keltikangas-Jarvinen Genetic Variants in the DRD2 Gene Moderate the Relationship Between Stressful Life Events and Depressive Symptoms in Adults: Cardiovascular Risk in Young Finns Study Psychosom Med, June 1, 2007; 69(5): 391 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Zarrindast, M. Farahmandfar, P. Rostami, and A. Rezayof The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice J Psychopharmacol, January 1, 2006; 20(1): 59 - 66. [Abstract] [PDF] |
||||
![]() |
L. Yao, P. Fan, Z. Jiang, W. S. Mailliard, A. S. Gordon, and I. Diamond Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-{beta}{gamma} dimers PNAS, November 25, 2003; 100(24): 14379 - 14384. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Sim-Selley, D. E. Selley, L. J. Vogt, S. R. Childers, and T. J. Martin Chronic Heroin Self-Administration Desensitizes {micro} Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain J. Neurosci., June 15, 2000; 20(12): 4555 - 4562. [Abstract] [Full Text] [PDF] |
||||